View in EDS

EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis.

Saved in:
Bibliographic Details
Title: EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis.
Authors: Smonskey M; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA., Lasorsa E; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA., Rosario S; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA; Department of Molecular Pharmacology and Cancer Therapeutics, State University of New York at Buffalo, NY, USA., Kirk JS; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA., Hernandez-Ilizaliturri FJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA., Ellis L; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA; Department of Molecular Pharmacology and Cancer Therapeutics, State University of New York at Buffalo, NY, USA.
Source: Oncoscience [Oncoscience] 2016 Jan 29; Vol. 3 (1), pp. 21-30. Date of Electronic Publication: 2016 Jan 29 (Print Publication: 2016).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals LLC Country of Publication: United States NLM ID: 101636666 Publication Model: eCollection Cited Medium: Print ISSN: 2331-4737 (Print) Linking ISSN: 23314737 NLM ISO Abbreviation: Oncoscience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26973857
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Smonskey+M%22">Smonskey M</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lasorsa+E%22">Lasorsa E</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rosario+S%22">Rosario S</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA; Department of Molecular Pharmacology and Cancer Therapeutics, State University of New York at Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kirk+JS%22">Kirk JS</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hernandez-Ilizaliturri+FJ%22">Hernandez-Ilizaliturri FJ</searchLink>; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ellis+L%22">Ellis L</searchLink>; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA; Department of Molecular Pharmacology and Cancer Therapeutics, State University of New York at Buffalo, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101636666%22">Oncoscience</searchLink> [Oncoscience] 2016 Jan 29; Vol. 3 (1), pp. 21-30. <i>Date of Electronic Publication: </i>2016 Jan 29 (<i>Print Publication: </i>2016).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals+LLC%22">Impact Journals LLC </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101636666 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2331-4737 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223314737%22">23314737 </searchLink><i>NLM ISO Abbreviation: </i>Oncoscience <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26973857
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncoscience.288
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 21
    Titles:
      – TitleFull: EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Smonskey M
      – PersonEntity:
          Name:
            NameFull: Lasorsa E
      – PersonEntity:
          Name:
            NameFull: Rosario S
      – PersonEntity:
          Name:
            NameFull: Kirk JS
      – PersonEntity:
          Name:
            NameFull: Hernandez-Ilizaliturri FJ
      – PersonEntity:
          Name:
            NameFull: Ellis L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 01
              Text: 2016 Jan 29
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 2331-4737
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoscience
              Type: main
ResultId 1